Bank of Nova Scotia Purchases New Shares in Revvity Inc. $RVTY

Bank of Nova Scotia purchased a new position in Revvity Inc. (NYSE:RVTY) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,742 shares of the company’s stock, valued at approximately $2,308,000.

A number of other institutional investors have also added to or reduced their stakes in the company. New Mexico Educational Retirement Board lifted its position in Revvity by 1.9% during the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock valued at $524,000 after buying an additional 100 shares during the period. Allworth Financial LP increased its stake in shares of Revvity by 8.9% in the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after acquiring an additional 104 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after acquiring an additional 109 shares during the period. HighTower Advisors LLC lifted its position in Revvity by 2.6% during the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after acquiring an additional 129 shares during the period. Finally, Cary Street Partners Financial LLC boosted its stake in Revvity by 1.6% during the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after acquiring an additional 141 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Up 1.2%

Shares of NYSE RVTY opened at $126.31 on Thursday. The firm’s 50 day moving average price is $112.94 and its 200-day moving average price is $100.82. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $126.90. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The company has a market cap of $14.09 billion, a PE ratio of 60.15, a P/E/G ratio of 2.27 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. During the same period in the previous year, the business earned $1.18 EPS. The firm’s revenue for the quarter was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities research analysts expect that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is 13.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on RVTY shares. Stifel Nicolaus decreased their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Wolfe Research began coverage on Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. Finally, Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price on the stock. Three investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat.com, Revvity currently has a consensus rating of “Hold” and an average price target of $108.36.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.